Search consultations

Consultation

He Ara Oranga draft framework

The Initial Mental Health and Wellbeing Commission (the ‘Initial Commission’) was established in November 2019 to maintain the momentum of He Ara Oranga, the Government Inquiry into Mental Health and Addiction in Aotearoa while a permanent Commission is established as an independent Crown entity.  Visit the Initial Commission’s website for more information about the role of the Initial Commission.
When established in February 2021, the Commission will oversee the performance of the whole mental health and wellbeing system, provide leadership and support, and challenge it to perform better.

He Ara Oranga wellbeing outcomes framework (attached)
The Initial Commission has been tasked to develop a wellbeing outcomes framework, with relevance to mental health and addiction. The framework is called the 'He Ara Oranga wellbeing outcomes framework' to reflect the pathway to wellness and our role in ensuring the legacy of He Ara Oranga continues.
The purpose of this outcomes framework is to support the mental health and wellbeing system to understand, measure and inform improved outcomes for Aotearoa, at both population (everyone in Aotearoa) and service levels (people and whānau who use mental health and addiction services).
This framework is in development. We are currently focused on the concepts to include in the outcomes framework. Later in the year, we will start the 'data phase' to work through the indicators, measures, data sources and data gaps.

Seeking your views
We are now testing the draft outcomes framework. We are asking for your views on:

  • Six areas of wellbeing
  • Vision statement
  • Our principles

Please provide feedback to sue.gasquoine@nzno.org.nz by Fri Sep 4th 2020.

Read or Download
Posted in: Consultations

Endorsement of CNE Activity

The NZ College of Primary Health Care Nurses (NZNO) supports continued nursing education (CNE) providers to ensure our members have access to a library of quality courses, conferences, workshops and online activities that are relevant to primary health care nursing.  This in turn supports members to meet their continuing professional development (CPD) requirements as per Nursing Council NZ (NCNZ) of minimum of 60 hours over a 3-year period (NCNZ 2008).

The NZCPHCN has developed this policy to support applications for endorsement of CNE, which indicates the college has reviewed a CNE activity to ensure it meets the quality criteria of the college.

Further information can be seen here
/Portals/0/Files/Documents/Groups/Primary%20Healthcare%20Nurses/2020-08-19%20NZCPHCN%20Endorsment%20of%20Education%20Application%20Form.docx

Please review this policy and provide feedback using track changes Word document or via email text. Please indicate which page/section you are referring to. Individual or group submissions are welcome.

Thank you for your consideration of this proposed policy.

Please send feedback to nicola.thompson@nmdhb.govt.nz by Thursday 10 September 2020.

Read or Download
Posted in: Consultations

Primary Health Care Nurse Position Description

The NZ College of Primary Health Care Nurses invite you to provide feedback on the Primary Health Care Nurse Position Description. This position description aligns with the Aotearoa NZ Primary Health Care Nurses Standards of Practice. These current Standards of Practice were endorsed in 2019, however the subsequent Position Description, that began development in 2019, has been delayed until now due to COVID-19.

Further information can be seen here:
/Portals/0/Files/Documents/Groups/Primary%20Healthcare%20Nurses/2020-08-19%20Final%20Generic%20PHC%20Nurse%20PD%20Dec%202019.docx 

Please review this document and provide feedback using track changes Word document or via email text. Please indicate which page/section you are referring to. Individual or group submissions are welcome.

Read or Download
Posted in: Consultations

Proposal For New Calcineurin Inhibitor Listings

NZNO warmly invites your feedback on PHARMAC’s proposal to list two new medicines on the Pharmaceutical Schedule with Special Authority restrictions and Hospital Indication restrictions.

As the Tender process is still in progress, the brand names, pricing and timing for these products to be listed is still to be determined; however, PHARMAC is seeking your feedback on the proposed restrictions for these products:

  • Pimecrolimus cream 1% for eczema (atopic dermatitis) on the eyelid
  • Tacrolimus ointment 0.1% for eczema (atopic dermatitis) on the face

Further information can be seen here.

Please note the short consultation timeframe.

If the Policy Team receives no feedback, NZNO will not make a submission.

Please send feedback to PolicyAnalysts@nzno.org.nz by 21 August 2020.

Posted in: Consultations

Draft Standard for Occupational Protective Gloves

NZNO warmly invites your feedback on this Draft Standard. The objective of the Standard is to specify the general requirements and relevant test procedures for glove design and construction, innocuousness, comfort and efficiency, as well as the marking and information supplied by the manufacturer applicable to all protective gloves.

For further information, including detail about what is and is not covered by the Standard, please refer to the attached Draft Standard itself. 

Please send feedback to PolicyAnalysts@nzno.org.nz by 8 September 2020.

Read or Download
Posted in: Consultations

Proposal To Modify Contracting Arrangements

Every year PHARMAC invites tenders for the supply of certain medicines to DHB hospitals and/or to community pharmacies in New Zealand. This year, they are also seeking feedback on a proposed new approach to competitive procurement.

NZNO warmly invites your feedback on PHARMAC’s proposal to introduce Principal Supply Status (rather than Sole Supply Status or Hospital Supply Status). Principal Supply Status would allow PHARMAC the flexibility to fund alternative brands in the community.

For further information about the proposal, and the areas that PHARMAC particularly wants feedback on, please refer here.

Please send feedback to PolicyAnalysts@nzno.org.nz by 21 August 2020.

Posted in: Consultations

Proposal To Fund An Additional Brand Of Budesonide With Eformoterol Dry Powder Inhaler

NZNO warmly invites your feedback on PHARMAC’s proposal to fund an additional brand (DuoResp Spiromax) of two of the three funded strengths of budesonide with eformoterol dry powder inhaler from 1 October 2020 through a provisional agreement with Teva Pharmaceuticals Ltd ("Teva").

Further information can be seen here.

Please note the short consultation timeframe.

If the Policy Team receives no feedback, NZNO will not make a submission.

Please send feedback to PolicyAnalysts@nzno.org.nz by 10 August 2020.

Posted in: Consultations

Revocation and Replacement of the Health Information Privacy Code under the Privacy Act 2020

NZNO welcome your feedback on proposed changes made to the Health Information Privacy Code. The changes are not intended to enact policy changes, aside from those implemented in the Privacy Act 2020.

The key updates to this code which may be relevant to nurses are:

  • If the lawful purpose for which health information about an individual is collected does not require the collection of an individual’s identifying information, the health agency may not require the individual’s identifying information.
  • A new exception to allow collection from a source other than the individual where necessary to prevent or lessen a serious threat to the life or health of the individual concerned or any other individual
  • A new information privacy principle relating to crossborder disclosures and other substantive and technical amendments made to the information privacy principles in the new Act;
  • Updating clause numbering where previous amendments to the 1994 code has led to such numbering being out of sequence;
  • Removal of section notes and square brackets relating to previous amendments;
  • Decapitalisation of some words, such as “code of practice” and “rule”.

The proposed code broadly has retained the ordering of subrules in the 1994 code, including where that order differs from the information privacy principles in the Act.

The information paper can be found here.

A copy of the proposed code, which sets out the changes in bold and with commentary can be found here.

Please send feedback to PolicyAnalysts@nzno.org.nz by 7 August 2020.

Posted in: Consultations

Worksafe proposed changes to the Workplace Exposure Standards (WES) of 18 substances and the Biological Exposure Indices (BEI) of 4 substances

NZNO welcomes your feedback on proposed changes to the Workplace Exposure Standards (WES) of 18 substances and the Biological Exposure Indices (BEI) of 4 substances.  

WES and BEI are important tools for monitoring worker’s biological and airborne exposure. WES are values that refer to the airborne concentration of substances. BEI are guidance values for assessing biological monitoring results which measures the concentration of a substance – or its breakdown products - in blood or urine or even exhaled air. The monitoring result is compared to the BEI established for the specific substance.

18 substances of WES:

  1. Acetaldehyde
  2. Allyl glycidyl ether
  3. Aniline and homologues
  4. Arsenic
  5. Benzene
  6. Cadmium and cadmium compounds
  7. Chromium compounds
  8. Copper
  9. Diethyl sulphate
  10. 4,6-Dinotro-o-cresol
  11. 1,4 Dioxane
  12. Formaldehyde
  13. Hydroquinone
  14. Phenol
  15. Synthetic mineral fibres
  16. Vanadium
  17. Vinyl Acetate
  18. Zinc Oxide

4 substances of BEI:

  1. Arsenic
  2. Benzene
  3. Cadmium and cadmium compounds
  4. Phenol

Please find further consultation information here.

Further information on WES, including the meaning of WES-TWA and WES-STEL, and BEI is provided in the Glossary sections of the relevant proposal documents.

Please send feedback to PolicyAnalysts@nzno.org.nz by 14 August 2020.

Posted in: Consultations

Proposed Guidelines for the Posthumous Use of Gametes, Reproductive Tissue and Stored Embryos

NZNO warmly invites your feedback on draft guidelines for the use of gametes and reproductive tissue from deceased people and already stored embryos from the now deceased. These guidelines are proposed to replace Guidelines for the Storage, Use, and Disposal of Sperm from a Deceased Man (released in 2000).

Feedback from a 2018 public consultation (Phase One) has informed the development of the new document. It incorporates technical and sociological changes, including taking into account stored embryos, reproductive tissue (from ovaries and testes) and all gametes.

The draft guidelines are attached for your review. You are welcome to provide your feedback in an email or use ACART’s feedback form (also attached) to send us your feedback. We will incorporate your feedback into the NZNO response. 

Please send feedback to PolicyAnalysts@nzno.org.nz by 2 September 2020.

Posted in: Consultations

Proposal To List Medical Devices Supplied By Obex Medical Ltd

NZNO warmly invites your feedback on PHARMAC’s proposal to list 422 medical devices supplied by Obex Medical Ltd in the  following categories:

  • surgical suction, chest and wound drainage; and
  • obstetrics and gynaecology.

Further information, including the list of products can be seen here.

Please note the short consultation timeframe.

If the Policy Team receives no feedback, NZNO will not make a submission.

Please send feedback to PolicyAnalysts@nzno.org.nz by 28 July 2020.

Posted in: Consultations

245678910Last

Notify me when this page changes

Enter your email address below to receive alerts when this page is updated.

Sign up below to receive an email when we update this page

Email:  
Captcha:
CAPTCHA image
Enter the code shown above in the box below.